Advances in the Management of Gastric and Gastroesophageal Cancers.

Item

http://www.wikidata.org/entity/Q38697255

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Advances in the Management of Gastric and Gastroesophageal Cancers.

@en

type

Item

label

Advances in the Management of Gastric and Gastroesophageal Cancers.

@en

prefLabel

Advances in the Management of Gastric and Gastroesophageal Cancers.

@en

P1476

Advances in the Management of Gastric and Gastroesophageal Cancers

@en

P2093

Jennifer Y Wo

http://www.w3.org/2001/XMLSchema#string

Theodore S Hong

http://www.w3.org/2001/XMLSchema#string

P2860

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma.

Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS).

Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response.

Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction.

Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial.

Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial.

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.

P2888

s11912-015-0493-6

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11912-015-0493-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sophia C Kamran

P577

2016-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1024131246

http://www.w3.org/2001/XMLSchema#string

P698

26769118

http://www.w3.org/2001/XMLSchema#string